Cargando…

L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells

SIMPLE SUMMARY: Toll-like receptor (TLR) agonists induce strong immune responses, which are used as an effective adjuvant system for vaccine development. L-pampo™ is our innovative adjuvant system containing TLR2 and TLR3 agonists, and it provides robust humoral and cellular immune responses against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heo, Yoonki, Ko, Eunbyeol, Park, Sejung, Park, Si-On, Ahn, Byung-Cheol, Yum, Jung-Sun, Chun, Eunyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417701/ https://www.ncbi.nlm.nih.gov/pubmed/37568794 http://dx.doi.org/10.3390/cancers15153978

Ejemplares similares

Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade
por: Lee, Won Suk, et al.
Publicado: (2022)

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses
por: Gutjahr, Alice, et al.
Publicado: (2020)

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants
por: Strobl, Sebastian, et al.
Publicado: (2022)

COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity
por: Jeong, Soo-Kyung, et al.
Publicado: (2021)

Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists
por: Kamgang, Richard Kenmoe, et al.
Publicado: (2008)

In adjuvant-induced arthritis the disease-triggering adjuvant squalene accumulates in draining lymph nodes but not affected joints
por: Holm, BC, et al.
Publicado: (2001)

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
por: Van Hoeven, Neal, et al.
Publicado: (2017)

S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes
por: Nakagawa, Takayuki, et al.
Publicado: (2021)

Regulation of Dendritic Cell Migration to the Draining Lymph Node: Impact on T Lymphocyte Traffic and Priming
por: Martín-Fontecha, Alfonso, et al.
Publicado: (2003)

Migratory dendritic cells in skin-draining lymph nodes have nickel-binding capabilities
por: Kuroishi, Toshinobu, et al.
Publicado: (2020)

Vaccinia Virus Infection Inhibits Skin Dendritic Cell Migration to the Draining Lymph Node
por: Aggio, Juliana Bernardi, et al.
Publicado: (2021)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
por: Shukla, Nikunj M., et al.
Publicado: (2012)

Constitutive Presentation of a Natural Tissue Autoantigen Exclusively by Dendritic Cells in the Draining Lymph Node
por: Scheinecker, Clemens, et al.
Publicado: (2002)

First Genomic Analysis of Dendritic Cells from Lung and Draining Lymph Nodes in Murine Asthma
por: Tschernig, Thomas, et al.
Publicado: (2015)

Dynamic Changes in the Phenotype of Dendritic Cells in the Uterus and Uterine Draining Lymph Nodes After Coitus
por: Yasuda, Ippei, et al.
Publicado: (2020)

Boiling histotripsy induces dendritic cell activation and acquisition of antigen in tumor draining lymph nodes
por: Thim, Eric A., et al.
Publicado: (2023)

A novel defined TLR3 agonist as an effective vaccine adjuvant
por: Ko, Kwang Hyun, et al.
Publicado: (2023)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013)

The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes
por: Wui, Seo Ri, et al.
Publicado: (2021)

HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy
por: Bravo, Alicia Inés, et al.
Publicado: (2023)

Paracoccidioides brasilinsis-Induced Migration of Dendritic Cells and Subsequent T-Cell Activation in the Lung-Draining Lymph Nodes
por: Silvana dos Santos, Suelen, et al.
Publicado: (2011)

Leishmania amazonensis infection impairs dendritic cell migration from the inflammatory site to the draining lymph node
por: Hermida, Micely DR, et al.
Publicado: (2014)

Pertussis toxin suppresses dendritic cell-mediated delivery of B. pertussis into lung-draining lymph nodes
por: Klimova, Nela, et al.
Publicado: (2022)

CCL5-producing migratory dendritic cells guide CCR5(+) monocytes into the draining lymph nodes
por: Rawat, Kavita, et al.
Publicado: (2023)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
por: Kaushik, Deepender, et al.
Publicado: (2020)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
por: Birmachu, Woubalem, et al.
Publicado: (2007)

Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703
por: Schmidt, Manuel, et al.
Publicado: (2015)

An efficient and scalable synthesis of potent TLR2 agonistic PAM(2)CSK(4)
por: Kaur, Arshpreet, et al.
Publicado: (2018)

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
por: Guzelj, Samo, et al.
Publicado: (2022)

Dynamics of CD11c(+) dendritic cell subsets in lymph nodes draining the site of intestinal nematode infection
por: Balic, Adam, et al.
Publicado: (2009)

Dendritic Cell Migration to Skin-Draining Lymph Nodes Is Controlled by Dermatan Sulfate and Determines Adaptive Immunity Magnitude
por: Nadafi, Reza, et al.
Publicado: (2018)

ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming
por: Wangmo, Dechen, et al.
Publicado: (2021)

Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE(2) Production
por: Lee, Jinhee, et al.
Publicado: (2015)

slanDCs in carcinoma-draining lymph nodes
por: Vermi, William, et al.
Publicado: (2014)

Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
por: Kang, Tae Heung, et al.
Publicado: (2015)

Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine
por: Lasalvia-Prisco, Eduardo, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_thups59jamgf44u2fv23fr2iqs